Dementia Caregivers and Contemplative Practice: A Pilot Study

The goal of this study is to test the contemplative practice is feasible and acceptable among informal dementia caregivers population at all stages.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Loneliness

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Nevada Las Vegas

Las Vegas, Nevada, 89154, United States

About this study

It will also examine the benefits of this intervention and compare the outcomes between two groups (intervention and wait-list control).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Dementia Family Caregivers
At least cared for dementia care receipient more than 6 months

Exclusion criteria

If they have meditated less than 2 months ago
Cognitive or language barrier that would make it difficult to understand and sign the informed consent

Treatment and study plan

Contemplative Practice

Behavioral

Contemplative practice included Maitribodh Sambodh Dhyaan (MSD), which was designed to increase feeling of love and connection by including most of components of different contemplative practices such as breath watch, mantra or vibrational sound chant, focused meditation, and visualization followed by loving-kindness or a gratitude exercise at the end.

Primary outcomes

Change in Loneliness

Time frame: baseline, at 10 days and 21 days of Matribodh Sambodh Dhyaan practice (meditation), and at 30 days and 60 days follow-up.

The UCLA 3-item Loneliness scale will be used to measure loneliness. The scores on this scale range from 3 to 9, the highest scores indicative of a higher level of loneliness. The scale is called UCLA 3-item scale but UCLA is representative of University of California Los Angeles.

Sponsors and collaborators

Lead sponsor

University of Nevada, Las Vegas

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Oct 10, 2023
Registry last updated: Apr 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed